
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| EB | 1,774 | 68.4% | -1.17 | 787 | 97.3% |
| CRE(R) | 385 | 14.9% | -7.59 | 2 | 0.2% |
| CentralBrain-unspecified | 221 | 8.5% | -3.47 | 20 | 2.5% |
| LAL(R) | 102 | 3.9% | -inf | 0 | 0.0% |
| bL(R) | 42 | 1.6% | -inf | 0 | 0.0% |
| GA(R) | 32 | 1.2% | -inf | 0 | 0.0% |
| BU(R) | 25 | 1.0% | -inf | 0 | 0.0% |
| ROB(R) | 11 | 0.4% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns ER3a_b | % In | CV |
|---|---|---|---|---|---|
| ER3a_b (L) | 3 | GABA | 106.3 | 12.6% | 0.1 |
| ER3a_c (R) | 2 | GABA | 88 | 10.5% | 0.1 |
| PLP046 (R) | 6 | Glu | 71 | 8.4% | 1.0 |
| ER3a_c (L) | 2 | GABA | 70.7 | 8.4% | 0.1 |
| ER3a_b (R) | 3 | GABA | 58 | 6.9% | 0.1 |
| ER3a_a (R) | 7 | GABA | 42.7 | 5.1% | 0.7 |
| ER3a_a (L) | 8 | GABA | 42.7 | 5.1% | 0.3 |
| LHPV6q1 (L) | 1 | unc | 38.7 | 4.6% | 0.0 |
| ExR7 (L) | 2 | ACh | 36.3 | 4.3% | 0.1 |
| ExR7 (R) | 2 | ACh | 35.7 | 4.2% | 0.0 |
| ER3a_d (L) | 3 | GABA | 32.7 | 3.9% | 0.9 |
| EL (L) | 9 | OA | 25.7 | 3.0% | 0.4 |
| EL (R) | 9 | OA | 21 | 2.5% | 0.8 |
| LHPV6q1 (R) | 1 | unc | 18.7 | 2.2% | 0.0 |
| ExR1 (R) | 2 | ACh | 16 | 1.9% | 0.0 |
| ER3a_d (R) | 2 | GABA | 15.7 | 1.9% | 0.6 |
| ExR1 (L) | 2 | ACh | 15 | 1.8% | 0.1 |
| ER5 (L) | 11 | GABA | 14.7 | 1.7% | 0.4 |
| ER5 (R) | 9 | GABA | 11 | 1.3% | 0.7 |
| LAL138 (L) | 1 | GABA | 10.7 | 1.3% | 0.0 |
| ER3m (R) | 6 | GABA | 9.3 | 1.1% | 0.5 |
| ER3m (L) | 9 | GABA | 7.7 | 0.9% | 0.7 |
| LHPV5l1 (R) | 1 | ACh | 6.3 | 0.8% | 0.0 |
| SMP183 (R) | 1 | ACh | 5 | 0.6% | 0.0 |
| ER1_a (R) | 2 | GABA | 3 | 0.4% | 0.1 |
| LAL203 (R) | 2 | ACh | 2.7 | 0.3% | 0.5 |
| LAL047 (R) | 1 | GABA | 2 | 0.2% | 0.0 |
| DGI (R) | 1 | Glu | 2 | 0.2% | 0.0 |
| ExR3 (R) | 1 | 5-HT | 2 | 0.2% | 0.0 |
| DGI (L) | 1 | Glu | 1.7 | 0.2% | 0.0 |
| EPG (L) | 5 | ACh | 1.7 | 0.2% | 0.0 |
| PEG (L) | 3 | ACh | 1.3 | 0.2% | 0.4 |
| WED020_b (R) | 1 | ACh | 1.3 | 0.2% | 0.0 |
| ER2_c (L) | 2 | GABA | 1.3 | 0.2% | 0.5 |
| FB3C (R) | 2 | GABA | 1.3 | 0.2% | 0.0 |
| WEDPN7C (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| ExR3 (L) | 1 | 5-HT | 1 | 0.1% | 0.0 |
| FB1C (R) | 1 | DA | 1 | 0.1% | 0.0 |
| PLP044 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB4112 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| SMP238 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| ER2_a (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| ER3d_b (R) | 2 | GABA | 1 | 0.1% | 0.3 |
| LAL064 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP142 (L) | 1 | unc | 0.7 | 0.1% | 0.0 |
| SMP188 (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| ER3d_e (R) | 2 | GABA | 0.7 | 0.1% | 0.0 |
| ER3d_c (L) | 2 | GABA | 0.7 | 0.1% | 0.0 |
| LAL055 (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| LAL100 (R) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| PFR_a (L) | 2 | unc | 0.7 | 0.1% | 0.0 |
| ER3d_a (R) | 2 | GABA | 0.7 | 0.1% | 0.0 |
| ER3d_a (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ATL013 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| CB2447 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| ER3d_e (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| WED034 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| LAL013 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| ER4d (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| SMP001 (R) | 1 | unc | 0.3 | 0.0% | 0.0 |
| WED038 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| ER2_d (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| PFL1 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| ExR2 (R) | 1 | DA | 0.3 | 0.0% | 0.0 |
| PFGs (L) | 1 | unc | 0.3 | 0.0% | 0.0 |
| SMP177 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| ExR6 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| EPGt (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| CB4183 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| CRE052 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER4d (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER3d_b (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| FB4C (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| ER2_a (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER2_c (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| LAL156_b (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| downstream partner | # | NT | conns ER3a_b | % Out | CV |
|---|---|---|---|---|---|
| ER3a_a (L) | 8 | GABA | 137 | 13.1% | 0.4 |
| ER3a_a (R) | 7 | GABA | 132.7 | 12.6% | 0.4 |
| ER3a_b (L) | 3 | GABA | 110 | 10.5% | 0.1 |
| EL (L) | 9 | OA | 97.7 | 9.3% | 0.2 |
| EL (R) | 9 | OA | 86.7 | 8.3% | 0.6 |
| ER3a_d (L) | 3 | GABA | 73.7 | 7.0% | 0.4 |
| ER3a_b (R) | 3 | GABA | 58 | 5.5% | 0.0 |
| ER3a_c (R) | 2 | GABA | 55 | 5.2% | 0.3 |
| ExR1 (R) | 2 | ACh | 50.3 | 4.8% | 0.3 |
| ER3a_d (R) | 2 | GABA | 50.3 | 4.8% | 0.3 |
| ExR1 (L) | 2 | ACh | 50.3 | 4.8% | 0.1 |
| ER3a_c (L) | 2 | GABA | 29.7 | 2.8% | 0.2 |
| ER3m (L) | 9 | GABA | 29.3 | 2.8% | 0.8 |
| ER3m (R) | 9 | GABA | 26.3 | 2.5% | 0.8 |
| EPG (R) | 13 | ACh | 9 | 0.9% | 1.1 |
| EPG (L) | 14 | ACh | 9 | 0.9% | 0.6 |
| ER5 (L) | 8 | GABA | 8.7 | 0.8% | 0.6 |
| ER5 (R) | 7 | GABA | 4.7 | 0.4% | 0.4 |
| ER4d (R) | 1 | GABA | 3.3 | 0.3% | 0.0 |
| ER3d_e (R) | 4 | GABA | 3 | 0.3% | 0.5 |
| ER2_a (L) | 3 | GABA | 2.7 | 0.3% | 0.6 |
| ER3d_b (R) | 6 | GABA | 2.7 | 0.3% | 0.4 |
| ER1_a (R) | 2 | GABA | 2 | 0.2% | 0.3 |
| ER2_c (R) | 1 | GABA | 1.7 | 0.2% | 0.0 |
| ExR5 (R) | 1 | Glu | 1.7 | 0.2% | 0.0 |
| ER2_c (L) | 2 | GABA | 1.7 | 0.2% | 0.2 |
| ExR3 (R) | 1 | 5-HT | 1.3 | 0.1% | 0.0 |
| ER2_a (R) | 2 | GABA | 1.3 | 0.1% | 0.5 |
| ER3d_d (R) | 3 | GABA | 1 | 0.1% | 0.0 |
| SIP028 (R) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| ExR3 (L) | 1 | 5-HT | 0.7 | 0.1% | 0.0 |
| PEG (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| ER3d_e (L) | 2 | GABA | 0.7 | 0.1% | 0.0 |
| ER3d_a (L) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| ER3d_a (R) | 2 | GABA | 0.7 | 0.1% | 0.0 |
| AN09A005 (L) | 1 | unc | 0.3 | 0.0% | 0.0 |
| ER1_c (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER3d_b (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER1_b (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| CB2245 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| CB2469 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| CB1504 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| WED155 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| LAL052 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| FB3C (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ExR7 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| ER3d_c (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ER2_d (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| PFL3 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |